Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 122, 2002 - Issue 1
Submit an article Journal homepage
25
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Enhanced Production of Matrix Metalloproteinase-2 in Human Head and Neck Carcinomas is Correlated with Lymph Node Metastasis

Ryo Kawata From the Departments of Otolaryngology, Osaka Medical College, Osaka, and Kyoto Prefectural University of Medicine, Kyoto, Japan
,
Taketoshi Shimada From the Departments of Otolaryngology, Osaka Medical College, Osaka, and Kyoto Prefectural University of Medicine, Kyoto, Japan
,
Susumu Maruyama From the Departments of Otolaryngology, Osaka Medical College, Osaka, and Kyoto Prefectural University of Medicine, Kyoto, Japan
,
Yasuo Hisa From the Departments of Otolaryngology, Osaka Medical College, Osaka, and Kyoto Prefectural University of Medicine, Kyoto, Japan
,
Hiroshi Takenaka From the Departments of Otolaryngology, Osaka Medical College, Osaka, and Kyoto Prefectural University of Medicine, Kyoto, Japan
&
Yasushi Murakami From the Departments of Otolaryngology, Osaka Medical College, Osaka, and Kyoto Prefectural University of Medicine, Kyoto, Japan
Pages 101-106 | Published online: 08 Jul 2009

  • Liotta LA, Tryggvason K, Garbisa S, Hart I, Fortz CM. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
  • Stettler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-73.
  • SaIo T, Liotta LA, Tryggvason K. Purification and characterization of murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. J Biol Chem 1983; 258: 2058-62.
  • Coolier IE, Wihelm SM, Eisen AZ, Manner BL, Grant GA. H-ras oncogene-transformed human bronchial cells (TBE-I) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 1988; 263: 6579-89.
  • Sato H, Kida Y, Mai M, Sasaki T. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7: 77-83.
  • Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stettler-Stevenson WG. Immunohistochemical distribution of type IV collagenases in normal, benign, and malignant breast tissue. Am J Pathol 1990; 136: 585-92.
  • Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase 2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol 1993; 99: 18-23.
  • Miyajima Y, Nakano R, Morimatsu M. Analysis of expression of matrix metalloproteinase-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 1995; 104: 678-84.
  • Charous SJ, Stricklin GP, Nanney LB, Nettervilte JL, Burkey BB. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 1997; 106: 271-8.
  • Yoshizaki T, Sato H, Maruyama Y, et al. Increased expression of membrane type-matrix metalloproteinase in head and neck carcinoma. Cancer 1997; 79: 139-44.
  • Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type 4 collagenase) using monoclonal antibodies. Clin Chim Acta 1993; 221: 91-103.
  • Lowry OH, Rosebrough AL, Ramdall RL. Protein measurements with the folin phenol reagent. J Biol Chem 1951; 193: 265-70.
  • Schultz RM, Silberman S, Persky B, Bajkowski AS, Camichael DF. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10. Cancer Res 1988; 48: 5539-45.
  • Khokha R, Waterhouse P, Yagel S, et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on swiss 3T3 cells. Science 1989; 243: 947-50.
  • Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric cancer. Int J Cancer 1996; 69: 9-16.
  • Tokuraku M, Sato H, Murakami S, Okada Y, Watanaba Y, Seiki M. Activation of the production of gelatinase A/72 kDa type 4 collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995; 64: 355-9.
  • Ueno H, Nakamura H, Inoue M, et al. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997; 57: 2055-60.
  • Nakamura H, Ueno H, Yamashita K, et al. Enhanced production and activation of progelatinase A mediated by membrane-type matrix metalloproteinases in human papillary thyroid carcinomas. Cancer Res 1999; 55: 467-73.
  • Vra H. Expression of type 4 collagenase and procollagen genes and its correlation with the tumorigenic, invasive and metastatic abilities of oncogene-transformed human bronchial cells. Cancer Res 1989; 49: 4615-21.
  • Endo K, Maehara Y, Baba H, et al. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer. Anticancer Res 1997; 17: 2253-8.
  • Garbisa S, Scagliotti G, Masiero L, et al. Correlation of serum metalloproteinase level with lung cancer metastasis and response to therapy. Cancer Res 1992; 52: 4548-9.
  • Gohji K, Fujimoto N, Hara I, et al. Serum matrix metalloproteinase 2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 1998; 79: 96-101.
  • Davis B, Waxman J, Wasan H. Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993; 53: 5365-9.
  • Shima I, Sasaguchi Y, Kusukawa J, et al. Production of matrix metalloproteinase 2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. Cancer 1992; 70: 2747-53.
  • Liotta LA, Stettler-Stevenson WG, Steegs PS. An imbalance of positive and negative regulation. Cell 1991 ; 64: 327-36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.